David A. Siegel Guardant Health, Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 2,367,800 shares of GH stock, worth $128 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
2,367,800
Previous 2,315,600
2.25%
Holding current value
$128 Million
Previous $70.7 Million
42.59%
% of portfolio
0.24%
Previous 0.17%
Shares
15 transactions
Others Institutions Holding GH
# of Institutions
403Shares Held
123MCall Options Held
1.43MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.1MShares$655 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$609 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$295 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$279 Million0.04% of portfolio
-
Baillie Gifford & CO4.81MShares$261 Million0.2% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.54B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...